Details for 2017714098
Up to date per 03.04.2026
Actions
Details for 2017714098
Granted/Registered
European Patent
13.03.2019 A
03.05.2023 B1
04.05.2016
US
201662331694 P
A61M 16/12 20060101AFI20221031BHEP
Owner
Mallinckrodt Pharmaceuticals Ireland LimitedCollege Business & Technology Park Cruiserath, Blanchardstown Dublin 15IE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
STANTON, John, P.2430 Commonwealth Avenue Madison, WI 53711US
BERNDT, John, V.277 Orchard Drive Oregon, WI 53575US
Information about Fees